📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIV. (2024)

First Author: McCabe L

Attributed to: Syndromic infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/qad.0000000000003947

PubMed Identifier: 38819839

Publication URI: http://europepmc.org/abstract/MED/38819839

Type: Journal Article/Review

Volume: 38

Parent Publication: AIDS (London, England)

Issue: 10

ISSN: 0269-9370